Phosphodiesterase 11A (PDE11A) genetic variants may increase susceptibility to prostatic cancer.
about
Is IGSF1 involved in human pituitary tumor formation?Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation.Cyclic AMP, protein kinase A, and phosphodiesterases: proceedings of an international workshopCyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets.p54nrb/NONO regulates cyclic AMP-dependent glucocorticoid production by modulating phosphodiesterase mRNA splicing and degradation.Phosphodiesterase sequence variants may predispose to prostate cancer.Identification of novel genetic variants in phosphodiesterase 8B (PDE8B), a cAMP-specific phosphodiesterase highly expressed in the adrenal cortex, in a cohort of patients with adrenal tumours.Phosphodiesterase 11A (PDE11A) gene defects in patients with acth-independent macronodular adrenal hyperplasia (AIMAH): functional variants may contribute to genetic susceptibility of bilateral adrenal tumorsPhosphodiesterase function and endocrine cells: links to human disease and roles in tumor development and treatmentPhosphodiesterases and adrenal Cushing in mice and humans.cAMP/PKA signaling defects in tumors: genetics and tissue-specific pluripotential cell-derived lesions in human and mouse.Clinical and molecular genetics of the phosphodiesterases (PDEs).A Role for Phosphodiesterase 11A (PDE11A) in the Formation of Social Memories and the Stabilization of Mood.Phosphodiesterase type 5 and cancers: progress and challenges.Comprehensive Analysis of Germline Variants in Mexican Patients with Hereditary Breast and Ovarian Cancer Susceptibility
P2860
Q30301093-56907075-D2DB-4906-8621-D4309D2DECACQ33682397-847DA120-F847-4DBC-A4AD-B737D99143A9Q34055579-0F0C88F1-ADC8-4D45-97B5-435BD94B4FEDQ34765802-C74AA430-8930-456C-8571-C701A3411C94Q35165187-6641A2FB-9B05-4A65-99E5-D4839C2E43A5Q35843428-E7DA777A-1374-4306-9241-233477947464Q35990225-DAD06413-44CF-473A-BED3-02420317DEDBQ36361438-81875CDF-4619-4C3C-9E58-93FBF21688F9Q36503940-534C7CEC-471A-42E2-B31E-8EAFE1E00CA8Q36514530-3009498D-0934-4C92-A810-932F1BFF6EFCQ36763148-14D5058E-E9EA-4863-8D04-35473D62FE42Q37657841-F2CBAE1A-FDD1-4097-91F1-80168A1BC585Q47147373-7FCCBB00-0DB9-4EDF-9E19-2CB4CD24B8EDQ47171803-79A2C403-2D79-4113-8190-66DD156FE4E1Q58930584-3F555A8B-FE13-4FA2-988D-ED890CC8F8CF
P2860
Phosphodiesterase 11A (PDE11A) genetic variants may increase susceptibility to prostatic cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Phosphodiesterase 11A (PDE11A) ...... ptibility to prostatic cancer.
@ast
Phosphodiesterase 11A (PDE11A) ...... ptibility to prostatic cancer.
@en
type
label
Phosphodiesterase 11A (PDE11A) ...... ptibility to prostatic cancer.
@ast
Phosphodiesterase 11A (PDE11A) ...... ptibility to prostatic cancer.
@en
prefLabel
Phosphodiesterase 11A (PDE11A) ...... ptibility to prostatic cancer.
@ast
Phosphodiesterase 11A (PDE11A) ...... ptibility to prostatic cancer.
@en
P2093
P2860
P50
P356
P1476
Phosphodiesterase 11A (PDE11A) ...... ptibility to prostatic cancer.
@en
P2093
Anelia Horvath
Anya Rothenbuhler
Fabio Rueda Faucz
Gustavo de Campos Molina
Madson Q Almeida
Marcelo Luiz Bendhack
Maria Nesterova
Rodrigo B Alexandre
P2860
P304
P356
10.1210/JC.2010-1655
P407
P50
P577
2010-09-29T00:00:00Z